Version history

{
  "content_md": "\n\n# Ms\n\n## Summary\n\nMs is a biological entity involved in regulating multiple key cellular pathways including autophagy, synaptic plasticity, and metabolic processes. Research indicates it plays significant roles in neurodegenerative contexts, particularly through interactions with disease-relevant genes and pathways implicated in cognitive decline and neuronal dysfunction.\n\n## Biological Function\n\nMs participates in the regulation and activation of several critical biological pathways:\n\n| Pathway | Relationship | Strength |\n|---------|-------------|----------|\n| Autophagy | Regulates | 0.60 |\n| Lysosomal Degradation | Activates | 0.60 |\n| Glycolysis | Activates | 0.60 |\n| mTOR | Regulates | 0.60 |\n| Synaptic Plasticity | Regulates | 0.60 |\n| Sphingolipid Metabolism | Regulates | 0.60 |\n| Lipid Metabolism | Regulates | 0.60 |\n| Epigenetic Regulation | Regulates | 0.60 |\n| DNA Methylation | Therapeutic Target | 0.60 |\n| Wnt Signaling | Therapeutic Target | 0.60 |\n\nThese broad regulatory functions position Ms as a central modulator of cellular homeostasis, energy metabolism, and neuronal function.\n\n## Key Relationships\n\n### Gene Interactions\n\n**Regulated Genes:**\n\n- **APP** (Amyloid Precursor Protein) — Strength: 0.65\n- **BACE1** (β-secretase 1) — Strength: 0.65\n- **ACTB** (β-Actin) — Strength: 0.65\n- **PPARA** (Peroxisome Proliferator Activated Receptor Alpha) — Strength: 0.65\n- **CAT** (Catalase) — Strength: 0.65\n- **SQSTM1** (p62/Sequestosome-1) — Strength: 0.65\n- **RPS6KB1** (S6 Kinase) — Strength: 0.65\n- **RAB7A** (Ras-related protein) — Strength: 0.65\n\n**Associated Genes:**\n\n- **MAX** (MYC-associated factor X) — Strength: 0.65\n- **CACNA1A** (Calcium channel) — Strength: 0.65\n\nThe strong associations with APP and BACE1 link Ms to amyloid processing pathways, while connections to SQSTM1 and RAB7A connect it to autophagy-lysosomal function.\n\n## Research Context\n\n### Active Hypotheses\n\nMs has been investigated through multiple mechanistic hypotheses in SciDEX:\n\n1. **Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to restore hippocampal-cortical connectivity in early MCI** (Score: 1.00)\n   - Explores modulation of PVALB in mild cognitive impairment\n\n2. **Metabolic Reprogramming to Reverse Senescence in Neurodegeneration** (Score: 1.00)\n   - Investigates targeting senescence mechanisms in neurodegenerative disease\n\n3. **TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration** (Score: 0.99)\n   - Examines TREM2 modulation to redirect disease-relevant processes\n\n4. **SASP Modulation Rather Than Cell Elimination** (Score: 0.98)\n   - Focuses on modulating NFKB1, IL1B, and BDNF in neurodegeneration\n\n5. **TREM2-Dependent Microglial Senescence Transition** (Score: 0.95)\n   - Investigates microglial senescence mechanisms via TREM2\n\n### Paper References\n\nThe entity is referenced in 10 publications:\n\n| PMID | Title |\n|------|-------|\n| 32508946 | Icariin Alleviates Glucocorticoid-Induced Osteoporosis through EphB4/Ephrin-B2 Axis |\n| 31944172 | Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells |\n| 39149513 | The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells |\n| 38179058 | An integrative analysis of single-cell and bulk transcriptome and bidirectional mendelian randomization analysis identified C1Q as a novel stimulated risk gene for Atherosclerosis |\n| 37532929 | Pharmacological targeting of netrin-1 inhibits EMT in cancer |\n\n## Disease Associations\n\nMs shows strongest associations with:\n\n- **Neurodegenerative Diseases** — Through TREM2-dependent astrocyte-microglia cross-talk and metabolic reprogramming hypotheses\n- **Mild Cognitive Impairment (MCI)** — Related to hippocampal-cortical connectivity restoration\n- **Alzheimer's Disease** — Implied by regulatory relationships with APP and BACE1\n\nThe convergence of autophagy regulation, amyloid pathway interactions (APP/BACE1), and microglial senescence mechanisms suggests Ms may play a protective or modulatory role in neuronal health and disease progression.\n\n---\n\n*Note: This entity's precise molecular identity should be verified in primary literature, as \"Ms\" may represent an abbreviation for a specific protein or gene.*\n## Genetic Variants\n\n*Gene: APP*  \n\n| Variant | Clinical Significance | Conditions |\n|---|---|---|\n| GRCh38/hg38 21q11.2-22.3(chr21:13644166-44968483)x3 | Pathogenic | not provided |\n",
  "entity_type": "disease",
  "kg_node_id": "ms",
  "refs_json": {
    "pubmed31944172": {
      "pmid": "31944172",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed32508946": {
      "pmid": "32508946",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed37532929": {
      "pmid": "37532929",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed38179058": {
      "pmid": "38179058",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "pubmed39149513": {
      "pmid": "39149513",
      "year": 0,
      "title": "",
      "authors": "[]",
      "journal": "",
      "strength": 0.5
    },
    "clinvar:4796384": {
      "id": "4796384",
      "url": "https://www.ncbi.nlm.nih.gov/clinvar/variation/4796384",
      "type": "clinvar",
      "title": "GRCh38/hg38 21q11.2-22.3(chr21:13644166-44968483)x3",
      "clinical_significance": "Pathogenic"
    }
  },
  "epistemic_status": "speculative",
  "word_count": 575,
  "source_repo": "scidex_generated"
}